Neurogene Inc.
Neurogene Inc. scores highest on Torque (57) and lowest on Earnings (16). Its PosiPenta is 39.06 out of 100, weaker than most similar companies.
On the Penta Grid this week, Neurogene Inc. is Grid #571 of 837 in the Healthcare sector in United States, and Grid #2,976 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Neurogene Inc. | 39.06 | 27 | 16 | 53 | 57 | 42 |
| REGENXBIO Inc. | 28.71 | 11 | 28 | 40 | 14 | 51 |
| NRC Health | 62.65 | 7 | 86 | 86 | 49 | 85 |
| AVITA Medical, Inc. | 56.36 | 0 | 54 | 96 | 98 | 35 |
| 908 Devices Inc. | 56.82 | 18 | 58 | 86 | 63 | 58 |
| Cerus Corporation | 46.44 | 11 | 74 | 64 | 43 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.61 |
| P/B ratio | 2.14 |
EEarnings
| Trailing EPS | ₹-477.36 |
| Forward EPS | ₹-542.20 |
NNitro
| Price | 2202.12 |
| 52-week high | 4135.25 |
| 52-week low | 1508.81 |
| Fall from 52-week high | 46.7% |
TTorque
| Return on equity (ROE) | -45.31% |
| Debt-to-equity | 0.04 |
AAnchor
| Beta (price swings) | 2.09 |
| Market cap | ₹4,406 Cr |
| Insider holding | 6.98% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Neurogene Inc.'s PosiPenta score?
Neurogene Inc.'s PosiPenta is 39.06 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Neurogene Inc. stand on the Penta Grid?
On the Penta Grid this week, Neurogene Inc. is Grid #571 of 837 in the Healthcare sector in United States, and Grid #2,976 of 4,000 in United States.
Which PosiPenta pillar is strongest for Neurogene Inc.?
Torque (durability), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Neurogene Inc.?
Earnings (growth), with a score of 16 out of 100: much weaker than most similar companies.
Has Neurogene Inc.'s PosiPenta changed since last week?
Yes, it rose 3.93 points, from 35.13 to 39.06.
PositoAI is for research and education only and is not investment advice.